Literature DB >> 27882167

Expression and functions of the STAT3-SCLIP pathway in chronic myeloid leukemia cells.

Li Li1, Yanlong Zheng1, Wanzhuo Xie1.   

Abstract

Chronic myeloid leukemia (CML) is a blood cell cancer with increased proliferation of granulocytes. Signal transducers and activators of transcription 3 (STAT3) is an important regulator of CML. To investigate the possible downstream factors of STAT3 and gain more insight into CML-related pathways, this study focused on the superior cervical ganglia protein 10-like protein (SCLIP, or SCG 10-like protein) and analyzed the functions of the STAT3-SCLIP pathway. The effects of STAT3 phosphorylation on SCLIP expression were examined by western blotting. Specific small interfering RNA (siRNA) was then used to knockdown SCLIP in the CML cell line K562 and the expression changes of STAT3 and factors further downstream, namely Bcl-2 and cyclin E1, were detected by RT-qPCR. Cell viability and apoptosis were also analyzed following the knockdown of SCLIP. Results showed a positive association between the phosphorylation of STAT3 and the expression of SCLIP. Knockdown of SCLIP inhibited the viability and induced the apoptosis of K562 cells. Knockdown of SCLIP did not affect the expression of STAT3 mRNA but downregulated the mRNA levels of Bcl-2 and cyclin E1. In conclusion, the results indicate that SCLIP is a direct downstream factor of STAT3, regulates Bcl-2 and cyclin E1 and mediates the viability and apoptosis of CML cells. Consisting of at least these four factors, the STAT3-SCLIP pathway might play critical roles in the regulation of CML. These data provided a more profound understanding of CML-related pathways.

Entities:  

Keywords:  Bcl-2; chronic myeloid leukemia; cyclin E1; signal transducers and activators of transcription 3; superior cervical ganglia 10-like protein

Year:  2016        PMID: 27882167      PMCID: PMC5103813          DOI: 10.3892/etm.2016.3768

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  30 in total

Review 1.  The molecular biology of chronic myeloid leukemia.

Authors:  M W Deininger; J M Goldman; J V Melo
Journal:  Blood       Date:  2000-11-15       Impact factor: 22.113

2.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

3.  Long-term outcome with dasatinib after imatinib failure in chronic-phase chronic myeloid leukemia: follow-up of a phase 3 study.

Authors:  Neil P Shah; François Guilhot; Jorge E Cortes; Charles A Schiffer; Philipp le Coutre; Tim H Brümmendorf; Hagop M Kantarjian; Andreas Hochhaus; Philippe Rousselot; Hesham Mohamed; Diane Healey; Michael Cunningham; Giuseppe Saglio
Journal:  Blood       Date:  2014-02-25       Impact factor: 22.113

4.  Cyclin E1 knockdown induces apoptosis in cancer cells.

Authors:  Esteban N Gurzov; Marta Izquierdo
Journal:  Neurol Res       Date:  2006-07       Impact factor: 2.448

Review 5.  Seeking the causes and solutions to imatinib-resistance in chronic myeloid leukemia.

Authors:  D Bixby; M Talpaz
Journal:  Leukemia       Date:  2010-11-19       Impact factor: 11.528

6.  PrLZ protects prostate cancer cells from apoptosis induced by androgen deprivation via the activation of Stat3/Bcl-2 pathway.

Authors:  Dong Zhang; Dalin He; Yan Xue; Ruoxiang Wang; Kaijie Wu; Hongjun Xie; Jin Zeng; Xinyang Wang; Haiyen E Zhau; Leland W K Chung; Luke S Chang; Lei Li
Journal:  Cancer Res       Date:  2011-03-08       Impact factor: 12.701

7.  Constitutive activation of JAKs and STATs in BCR-Abl-expressing cell lines and peripheral blood cells derived from leukemic patients.

Authors:  S K Chai; G L Nichols; P Rothman
Journal:  J Immunol       Date:  1997-11-15       Impact factor: 5.422

8.  SCG10-like protein (SCLIP) is a STAT3-interacting protein involved in maintaining epithelial morphology in MCF-7 breast cancer cells.

Authors:  Dominic C H Ng; Cheh P Lim; Bao H Lin; Tong Zhang; Xinmin Cao
Journal:  Biochem J       Date:  2009-12-14       Impact factor: 3.857

9.  MicroRNA-520a-5p displays a therapeutic effect upon chronic myelogenous leukemia cells by targeting STAT3 and enhances the anticarcinogenic role of capsaicin.

Authors:  Burçin Tezcanlı Kaymaz; Vildan Bozok Cetintaş; Cağdaş Aktan; Buket Kosova
Journal:  Tumour Biol       Date:  2014-05-30

10.  STAT pathway in the regulation of zoledronic acid-induced apoptosis in chronic myeloid leukemia cells.

Authors:  Hatice Demet Kiper; Burcin Tezcanli Kaymaz; Aysun Adan Gokbulut; Nur Selvi; Cigir Biray Avci; Buket Kosova; Guniz Iskender; Melis Kartal Yandim; Cumhur Gunduz; Fahri Sahin; Yusuf Baran; Guray Saydam
Journal:  Biomed Pharmacother       Date:  2013-05-07       Impact factor: 6.529

View more
  1 in total

1.  Using glycyrrhizic acid to target sumoylation processes during Epstein-Barr virus latency.

Authors:  Gretchen L Bentz; Angela J Lowrey; Dustin C Horne; Vy Nguyen; Austin R Satterfield; Tabithia D Ross; Abigail E Harrod; Olga N Uchakina; Robert J McKallip
Journal:  PLoS One       Date:  2019-05-24       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.